The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.
Open accessAbstract
Vascular smooth muscle cell (VSMC) proliferation after arterial injury is important in the pathogenesis of a number of vascular proliferative disorders, including atherosclerosis and restenosis after balloon angioplasty. Thus, a better understanding of the molecular mechanisms underlying VSMC proliferation in response to arterial injury would have important therapeutic implications for patients with atherosclerotic vascular disease. The p21 protein is a negative regulator of mammalian cell cycle progression that functions both by inhibiting cyclin dependent kinases (CDKs) required for the initiation of S phase, and by binding to and inhibiting the DNA polymerase delta co-factor, proliferating cell nuclear antigen (PCNA). In this report, we show that adenovirus-mediated over-expression of human p21 inhibits growth factor-stimulated VSMC proliferation in vitro by efficiently arresting VSMCs in the G1 phase of the cell cycle. This p21-associated cell cycle arrest is associated both with significant inhibition of the phosphorylation of the retinoblastoma gene product (Rb) and with the formation of complexes between p21 and PCNA in VSMCs. In addition, we demonstrate that localized arterial infection with a p21-encoding adenovirus at the time of balloon angioplasty significantly reduced neointimal hyperplasia in the rat carotid artery model of restenosis. Taken together, these studies demonstrate the important role of p21 in regulating Rb phosphorylation and cell cycle progression in VSMC, and suggest a novel cytostatic gene therapy approach for restenosis and related vascular proliferative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 1×
“The kinase activities of the cyclinD/CDK complexes can themselves be negatively regulated by several different molecules including p16, p21, and p27 (16-23).”
Backgroundp21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,336
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
Molecular themes in oncogenesis
Bishop, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90636-d · Cited by 1,637
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Clowes, A. W., Reidy, M. A., & Clowes, M. M. (1983) · PubMed · Cited by 1,437
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
Stein, C. A., & Cheng, Y.-C. (1993) · Science · doi:10.1126/science.8351515 · Cited by 1,303
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
Hinds, P. W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S. I., & Weinberg, R. A. (1992) · Cell · doi:10.1016/0092-8674(92)90249-c · Cited by 995
Liu, M. W., Roubin, G. S., & King, S. B. (1989) · Circulation · doi:10.1161/01.cir.79.6.1374 · Cited by 927
Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897
Ip, J. H., Fuster, V., Badimon, L., Badimon, J., Taubman, M. B., & Chesebro, J. H. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)92845-s · Cited by 765
NHLBI funding policies. Enhancing stability, predictability, and cost control.
Lenfant, C. (1994) · Circulation · doi:10.1161/01.cir.90.1.1 · Cited by 762
Potential Role of Human Cytomegalovirus and p53 Interaction in Coronary Restenosis
Speir, E., Modali, R., Huang, E.-S., Leon, M. B., Shawl, F., Finkel, T., & Epstein, S. E. (1994) · Science · doi:10.1126/science.8023160 · Cited by 753
Physical interaction of the retinoblastoma protein with human D cyclins
Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., & Weinberg, R. A. (1993) · Cell · doi:10.1016/0092-8674(93)90137-f · Cited by 744
Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
Simons, M., Edelman, E. R., DeKeyser, J.-L., Langer, R., & Rosenberg, R. D. (1992) · Nature · doi:10.1038/359067a0 · Cited by 731
Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair
Li, R., Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/371534a0 · Cited by 643
p21-containing cyclin kinases exist in both active and inactive states.
Zhang, H., Hannon, G. J., & Beach, D. (1994) · Genes & Development · doi:10.1101/gad.8.15.1750 · Cited by 632
The restenosis paradigm revisited: An alternative proposal for cellular mechanisms
Schwartz, R. S., Holmes, D. R., & Topol, E. J. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90389-5 · Cited by 563
Forrester, J. S., Fishbein, M., Helfant, R., & Fagin, J. (1991) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80196-2 · Cited by 557
Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1
Luo, Y., Hurwitz, J., & Massagué, J. (1995) · Nature · doi:10.1038/375159a0 · Cited by 549
Control of the yeast cell cycle by the Cdc28 protein kinase
Nasmyth, K. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90099-c · Cited by 486
Morishita, R., Gibbons, G. H., Ellison, K. E., Nakajima, M., Zhang, L., Kaneda, Y., Ogihara, T., & Dzau, V. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8474 · Cited by 458
Chang, M. W., Barr, E., Seltzer, J., Jiang, Y.-Q., Nabel, G. J., Nabel, E. G., Parmacek, M. S., & Leiden, J. M. (1995) · Science · doi:10.1126/science.7824950 · Cited by 446
Self-citationJoining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle
Peter, M. (1994) · Cell · doi:10.1016/0092-8674(94)90186-4 · Cited by 445
Percutaneous Transluminal Coronary Angioplasty
Landau, C., Lange, R. A., & Hillis, L. D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404073301407 · Cited by 445
A cascade model for restenosis. A special case of atherosclerosis progression.
Libby, P., Schwartz, D., Brogi, E., Tanaka, H., & Clinton, S. K. (1992) · PubMed · Cited by 437
Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial Injury
Ohno, T., Gordon, D., San, H., Pompili, V. J., Imperiale, M. J., Nabel, G. J., & Nabel, E. G. (1994) · Science · doi:10.1126/science.8047883 · Cited by 433
Flores-Rozas, H., Kelman, Z., Dean, F. B., Pan, Z. Q., Harper, J. W., Elledge, S. J., O'Donnell, M., & Hurwitz, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8655 · Cited by 416
Fingerle, J., Johnson, R., Clowes, A. W., Majesky, M. W., & Reidy, M. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8412 · Cited by 414
Owens, G. K., Loeb, A., Gordon, D., & Thompson, M. M. (1986) · The Journal of cell biology · doi:10.1083/jcb.102.2.343 · Cited by 412
Faulds, D., & Heel, R. C. (1990) · Drugs · doi:10.2165/00003495-199039040-00008 · Cited by 400
Thornton, M. A., Gruentzig, A. R., Hollman, J., King, S. B., & Douglas, J. S. (1984) · Circulation · doi:10.1161/01.cir.69.4.721 · Cited by 358
Regulation of the Ets-Related Transcription Factor Elf-1 by Binding to the Retinoblastoma Protein
Wang, C.-Y., Petryniak, B., Thompson, C. B., Kaelin, W. G., & Leiden, J. M. (1993) · Science · doi:10.1126/science.8493578 · Cited by 213
Self-citationCell death and the cell cycle: a relationship between transformation and neurodegeneration?
Heintz, N. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90103-t · Cited by 200
Guzman, R. J., Hirschowitz, E. A., Brody, S. L., Crystal, R. G., Epstein, S. E., & Finkel, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10732 · Cited by 184
Lindner, V, Olson, N. E., Clowes, A. W., & Reidy, M. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116085 · Cited by 159
Serruys, P. W. J. C., Rutsch, W. R., Danchin, N., et al. (1992) · RePub (Erasmus University Rotterdam) · Cited by 145
Tripathy, S. K., Goldwasser, E., Lu, M. M., Barr, E., & Leiden, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11557 · Cited by 117
Self-citationBlank, R. S., Thompson, M. M., & Owens, G. K. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.107.1.299 · Cited by 113
Escape from “horror autotoxicus”: Pathogenesis and treatment of autoimmune disease
Steinman, L. (1995) · Cell · doi:10.1016/0092-8674(95)90443-3 · Cited by 97
Kozarsky, K., S, M. G. B., & Wilson, J. M. (1993) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01233250 · Cited by 84
Percutaneous Transluminal Coronary Angioplasty
May, D., & Daley, K. (1994) · AORN Journal · doi:10.1016/s0001-2092(07)65338-1 · Cited by 12
Cited by
Selective Requirement for Src Kinases during VEGF-Induced Angiogenesis and Vascular Permeability
Eliceiri, B. P., Paul, R., Schwartzberg, P. L., Hood, J. D., Leng, J., & Cheresh, D. A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80221-x · Cited by 813
Reactive oxygen species are downstream mediators of p53-dependent apoptosis.
Johnson, T. M., Yu, Z. X., Ferrans, V. J., Lowenstein, R. A., & Finkel, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11848 · Cited by 596
Gallo, R., Padurean, A., Jayaraman, T., Marx, S., Roque, M., Adelman, S., Chesebro, J., Fallon, J., Fuster, V., Marks, A., et al. (1999) · Circulation · doi:10.1161/01.cir.99.16.2164 · Cited by 490
Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.
Law, R. E., Meehan, W. P., Xi, X. P., Graf, K., Wuthrich, D. A., Coats, W., Faxon, D., & Hsueh, W. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118991 · Cited by 476
Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor
Kato, Y., Tapping, R. I., Huang, S., Watson, M. H., Ulevitch, R. J., & Lee, J.-D. (1998) · Nature · doi:10.1038/27234 · Cited by 436
Metadata
- Authors
- Chang, M. W., Barr, E., Lu, M. M., Barton, K., & Leiden, J. M.
- Venue
- Journal of Clinical Investigation
- Published
- 1995-11-01
- Volume
- 96
- Issue
- 5
- Pages
- 2260-2268
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1995928382
- Cited by
- 354
- References
- 51
- FWCI
- 12.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.